Total Payments
$7,529
2024 Payments
$798.50
Companies
50
Transactions
440
Medicare Patients
609
Medicare Billing
$48,692
Payment Breakdown by Category
Food & Beverage$7,421 (98.6%)
Education$86.84 (1.2%)
Gifts$21.12 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,421 | 433 | 98.6% |
| Education | $86.84 | 6 | 1.2% |
| Gift | $21.12 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,461 | 66 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $583.18 | 29 | $0 (2024) |
| Novo Nordisk Inc | $567.32 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $482.94 | 27 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $431.49 | 44 | $0 (2021) |
| Lilly USA, LLC | $395.33 | 27 | $0 (2024) |
| Allergan, Inc. | $381.60 | 30 | $0 (2020) |
| PFIZER INC. | $352.45 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $280.68 | 19 | $0 (2022) |
| Daiichi Sankyo Inc. | $253.66 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.50 | 39 | Novo Nordisk Inc ($152.26) |
| 2023 | $1,269 | 59 | Lilly USA, LLC ($157.62) |
| 2022 | $869.42 | 51 | ABBVIE INC. ($181.28) |
| 2021 | $938.34 | 48 | AbbVie Inc. ($441.48) |
| 2020 | $965.96 | 62 | AbbVie Inc. ($248.10) |
| 2019 | $1,146 | 69 | AbbVie, Inc. ($268.02) |
| 2018 | $844.77 | 68 | Supernus Pharmaceuticals, Inc. ($178.12) |
| 2017 | $696.71 | 44 | Takeda Pharmaceuticals America, Inc. ($135.78) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Obesity | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Biological | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.05 | General |
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Biological | ||||||
| 07/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: PAIN | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Obesity | ||||||
| 06/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.72 | General |
| 05/02/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: HORMONE THERAPY | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Obesity | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 183 | 242 | $27,819 | $15,387 |
| 2022 | 3 | 143 | 198 | $16,490 | $10,773 |
| 2021 | 4 | 150 | 194 | $16,723 | $11,230 |
| 2020 | 4 | 133 | 185 | $17,385 | $11,302 |
Total Patients
609
Total Services
819
Medicare Billing
$48,692
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 177 | $22,093 | $11,619 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $2,964 | $2,059 | 69.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 23 | 23 | $1,435 | $903.90 | 63.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 23 | 23 | $1,326 | $805.27 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 147 | $14,559 | $8,887 | 61.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 25 | 25 | $1,024 | $990.35 | 96.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 26 | 26 | $906.62 | $895.07 | 98.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 119 | $12,644 | $7,693 | 60.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 31 | 31 | $1,270 | $1,244 | 97.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 33 | 33 | $1,151 | $1,151 | 100.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $1,659 | $1,142 | 68.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 128 | $13,420 | $8,178 | 60.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $2,413 | $1,596 | 66.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 20 | 20 | $819.40 | $799.80 | 97.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 21 | 21 | $732.27 | $728.77 | 99.5% |
About Dr. Michelle Webster, DO
Dr. Michelle Webster, DO is a Obstetrics & Gynecology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598717357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Webster, DO has received a total of $7,529 in payments from pharmaceutical and medical device companies, with $798.50 received in 2024. These payments were reported across 440 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,421).
As a Medicare-enrolled provider, Webster has provided services to 609 Medicare beneficiaries, totaling 819 services with total Medicare billing of $48,692. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Oklahoma City, OK
- Active Since 05/17/2006
- Last Updated 04/20/2008
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598717357
Products in Payments
- LO LOESTRIN FE (Drug) $534.20
- TROKENDI XR (Drug) $431.49
- Orilissa (Drug) $322.97
- TRINTELLIX (Drug) $296.98
- ORILISSA (Drug) $271.98
- PREMARIN (Drug) $256.58
- INJECTAFER (Drug) $253.66
- MYFEMBREE (Drug) $209.19
- MYRBETRIQ (Drug) $203.44
- ORIAHNN (Drug) $186.66
- SOLOSEC (Drug) $168.10
- Myrbetriq (Drug) $164.90
- NEXPLANON (Drug) $160.33
- Amitiza (Drug) $152.18
- Saxenda (Drug) $147.37
- QULIPTA (Drug) $134.19
- UBRELVY (Drug) $129.59
- BELSOMRA (Drug) $128.70
- CONTRAVE (Drug) $122.99
- MOUNJARO (Drug) $121.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Oklahoma City
Kathleen Moore, Md, MD
Obstetrics & Gynecology — Payments: $872,312
Obstetrics & Gynecology $872,312
Tori O'daniel, Md, MD
Obstetrics & Gynecology — Payments: $596,012
Obstetrics & Gynecology $596,012
Lieschen Quiroz, M.d, M.D
Obstetrics & Gynecology — Payments: $41,813
Obstetrics & Gynecology $41,813
Benjamin Barenberg, M.d, M.D
Obstetrics & Gynecology — Payments: $40,741
Obstetrics & Gynecology $40,741
Beverly Vavricka, Md, MD
Obstetrics & Gynecology — Payments: $26,266
Obstetrics & Gynecology $26,266
Catherine Hildebrand, Md, MD
Obstetrics & Gynecology — Payments: $12,587
Obstetrics & Gynecology $12,587